Portfolio company
Precision for Medicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides biomarker-driven clinical research and development services for pharmaceutical and biotechnology organisations to accelerate the commercialisation of personalised medicines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Precision Medicine Group
This company provides clinical research and commercialisation services to pharmaceutical and life sciences firms to support the development of next-generation therapies.
Oxford Cancer Biomarkers
This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.
Celleron Therapeutics
This biopharmaceutical company develops precision medicine drugs and companion diagnostics for cancer patients to provide personalised oncology treatments.
OneOme
This company provides pharmacogenomic testing and clinical software to help healthcare organisations and providers tailor medication decisions to a patient's genetic profile.
PrecisionLife
This company provides a combinatorial analytics platform for drug discovery and patient stratification to pharmaceutical firms and healthcare organisations.
MI Bioresearch
This contract research organisation provides preclinical oncology imaging and pharmacology services to pharmaceutical and biotechnology companies.
Acrivon Therapeutics
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
